Department of Paediatrics, Fribourg Hospital HFR and Faculty of Science and Medicine, University of Fribourg, Switzerland; Department of Paediatrics, The University of Melbourne, Parkville, Australia; Infectious Diseases Research Group, Murdoch Children's Research Institute, Parkville, Australia; Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Parkville, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Australia; Infectious Diseases Research Group, Murdoch Children's Research Institute, Parkville, Australia; Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Parkville, Australia.
J Infect. 2019 Dec;79(6):471-489. doi: 10.1016/j.jinf.2019.10.008. Epub 2019 Oct 18.
Antibiotics change the composition of the intestinal microbiota. The magnitude of the effect of antibiotics on the microbiota and whether the effects are short-term or persist long-term remain uncertain. In this review, we summarise studies that have investigated the effect of antibiotics on the composition of the human intestinal microbiota.
A systematic search was done to identify original studies that have investigated the effect of systemic antibiotics on the intestinal microbiota in humans.
We identified 129 studies investigating 2076 participants and 301 controls. Many studies reported a decrease in bacterial diversity with antibiotic treatment. Penicillin only had minor effects on the intestinal microbiota. Amoxicillin, amoxcillin/clavulanate, cephalosporins, lipopolyglycopeptides, macrolides, ketolides, clindamycin, tigecycline, quinolones and fosfomycin all increased abundance of Enterobacteriaea other than E. coli (mainly Citrobacter spp., Enterobacter spp. and Klebsiella spp.). Amoxcillin, cephalosporins, macrolides, clindamycin, quinolones and sulphonamides decreased abundance of E. coli, while amoxcillin/clavulante, in contrast to other penicillins, increased abundance of E. coli. Amoxicllin, piperacillin and ticarcillin, cephalosporins (except fifth generation cephalosporins), carbapenems and lipoglycopeptides were associated with increased abundance of Enterococcus spp., while macrolides and doxycycline decreased its abundance. Piperacillin and ticarcillin, carbapenems, macrolides, clindamycin and quinolones strongly decreased the abundance of anaerobic bacteria. In the studies that investigated persistence, the longest duration of changes was reported after treatment with ciprofloxacin (one year), clindamycin (two years) and clarithromycin plus metronidazole (four years). Many antibiotics were associated with a decrease in butyrate or butryrate-producing bacteria.
Antibiotics have profound and sometimes persisting effects on the intestinal microbiota, characterised by diminished abundance of beneficial commensals and increased abundance of potentially detrimental microorganisms. Understanding these effects will help tailor antibiotic treatment and the use of probiotics to minimise this 'collateral damage'.
抗生素会改变肠道微生物群的组成。抗生素对微生物群的影响程度以及这些影响是短期的还是长期持续的仍然不确定。在这篇综述中,我们总结了研究抗生素对人类肠道微生物群组成影响的研究。
系统地搜索了调查全身抗生素对人类肠道微生物群影响的原始研究。
我们确定了 129 项研究,涉及 2076 名参与者和 301 名对照。许多研究报告称,抗生素治疗后细菌多样性下降。青霉素对肠道微生物群的影响较小。阿莫西林、阿莫西林/克拉维酸、头孢菌素、脂多糖肽、大环内酯类、酮内酯类、克林霉素、替加环素、喹诺酮类和磷霉素均增加了除大肠杆菌以外的肠杆菌的丰度(主要为柠檬酸杆菌、肠杆菌和克雷伯菌)。阿莫西林、头孢菌素、大环内酯类、克林霉素、喹诺酮类和磺胺类药物减少了大肠杆菌的丰度,而阿莫西林/克拉维酸盐与其他青霉素不同,增加了大肠杆菌的丰度。阿莫西林、哌拉西林和替卡西林、头孢菌素(除第五代头孢菌素外)、碳青霉烯类和脂糖肽与肠球菌属丰度增加有关,而大环内酯类和强力霉素则减少了其丰度。哌拉西林和替卡西林、碳青霉烯类、大环内酯类、克林霉素和喹诺酮类药物强烈降低了厌氧菌的丰度。在调查持续性的研究中,报告的最长变化持续时间是在使用环丙沙星(一年)、克林霉素(两年)和克拉霉素加甲硝唑(四年)治疗后。许多抗生素与丁酸或丁酸产生菌的减少有关。
抗生素对肠道微生物群有深远的、有时是持久的影响,其特征是有益共生菌的丰度降低,潜在有害微生物的丰度增加。了解这些影响将有助于调整抗生素治疗和使用益生菌,以将这种“附带损害”降至最低。